© 2022 MJH Life Sciences and Contagion Live. All rights reserved.
© 2022 MJH Life Sciences™ and Contagion Live. All rights reserved.
August 16, 2019
In the August Editor-in-Chief's Letter, Dr. Jason Gallagher discusses how we can improve outpatient antimicrobial stewardship.
August 15, 2019
The story of penicillin and cefazolin.
August 14, 2019
Quick recognition is key to early initiation of treatment and long-term survival.
August 13, 2019
HIV / AIDS
There has been increasing interest in the association between neural tube defects, dolutegravir, and integrase inhibitors as a class since 4 cases were reported in 2018.
August 12, 2019
Optimal dosing of daptomycin is unknown, but study results suggest higher doses are required for successful clinical and microbiological outcomes.
August 09, 2019
Stewardship & Prevention
Optimizing the relationship between infection prevention and antimicrobial stewardship.
August 08, 2019
Emerging & Re-Emerging Infections
An update for clinical providers.
August 07, 2019
News and Breakthroughs
A novel NNRTI hits the market, but what place will it have in treatment?
August 06, 2019
In the Literature
Numerous studies need to be performed to ensure adequate antimicrobial dosing, partic­ularly in the setting of renal impairment and critical illness.
August 05, 2019
Fosfomycin is an attractive potential option because it does not cross-react with other antimicrobials, making it a good choice in patients with extensive drug allergies.
C difficile Awareness Month: Breakthroughs and Setbacks
C difficile, Antimicrobials, and the Patients Most Affected
European Commission Approves Sanofi-GSK COVID-19 Booster VidPrevtyn
Genetic Factors That Naturally Protect Against Severe COVID-19